Researchers Develop Disease Prediction Software
New software combines AI and machine learning to measure the significance of specific genomic biomarkers to predict diseases in individuals.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Diagnostic Technologies |
New software combines AI and machine learning to measure the significance of specific genomic biomarkers to predict diseases in individuals.
Read MorePosted by Chris Wolski | Jan 19, 2024 | Middleware & Software |
Low-code LIMS offer an adaptable, nimble platform, facilitating quick customization to cater to the specific, individualized needs of a lab.
Read MorePosted by Andy Lundin | Jan 19, 2024 | Education |
Industry leaders at COLA will share insights on advancements in lab science and crucial aspects of CLIA compliance and lab accreditation.
Read MorePosted by Chris Wolski | Jan 17, 2024 | Respiratory Disease |
This FDA De Novo marketing authorization signifies the first ever FDA authorization of a diagnostic tool of any type in lung fibrosis.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Melanoma, Molecular Diagnostics |
The molecular Skin Fluorescence Imaging System noninvasively identifies and assesses activity associated with melanoma development.
Read More